ArticleCureus2024
Atypical Onset and Imaging Characteristics in Non-demyelinating Myelin Oligodendrocyte Glycoprotein Antibody-Associated Encephalitis: A Case Report and Literature Review.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is typically associated with central nervous system inflammation and demyelination in younger populations; however, rare cases of isolated encephalitis in the elderly have been reported. This article presents the case of an 80-year-old male with mild cognitive impairment who developed progressive cognitive decline and a focal seizure. Despite negative imaging findings, elevated serum MOG antibody titers and pleocytosis in cerebrospinal fluid (CSF) analysis suggested MOG antibody encephalitis. Following treatment with intravenous immunoglobulin (IVIg), the patient showed significant cognitive improvement, and MOG antibody titers decreased, indicating a positive response. This case highlights the diverse clinical spectrum of MOGAD, demonstrating its potential to cause encephalitis in elderly individuals, even in the absence of typical imaging findings, and emphasizes the importance of promptly recognizing MOG antibody encephalitis to reduce associated mortality and morbidity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.